ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 1998; 5(2): 162-164


SERUM IMMUNOGLOBULINS AND COMPLEMENT LEVELS IN PATIENTS WITH ATOPIC DERMATITIS

 

Şenol DANE*,  Teoman ERDEM**,   Vedat ERTUNÇ*,   Lalenur DANE***

.



Abstract
Download PDF Post


 

In this study, to research the pathological role of immunological changes in atopic dermatitis, we investigated the serum immunoglobulins and complement levels and the correlations between severity scoring of atopic dermatitis (scorad index) and these parameters. There was no statistically signif cant difference in the serum IgA, IgM, IgE, and C4 levels between the patients with atopic dermatitis and controls. But, the serum C3 and IgG levels was signifcantly lower in the patients than in controls. There was no correlation between scorad index and the serum IgG, IgM, and IgE levels, but the negat ve correlat on between scorad ndex and the serum IgA and C3 levels and positive correlation between scorad index and the serum C4 levels. This findings suggest that immunoglobulins and complement system participates in inflammatory process in atopic dermatitis.

Key words: severity scoring of atopic dermatitis, immunoglobulins, complements





Bibliomed Article Statistics

33
31
32
27
34
19
29
16
14
27
24
13
R
E
A
D
S

11

15

10

7

10

11

13

9

13

11

18

3
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.